» Articles » PMID: 34128229

Perspectives for Therapy of Treatment-resistant Depression

Overview
Journal Br J Pharmacol
Publisher Wiley
Specialty Pharmacology
Date 2021 Jun 15
PMID 34128229
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

A high proportion of depressed patients fail to respond to antidepressant drug treatment. Treatment-resistant depression (TRD) is a major challenge for the psychopharmacology of mood disorders. Only in the past decade have novel treatments, including deep brain stimulation (DBS) and ketamine, been discovered that provide rapid and sometimes prolonged relief to a high proportion of TRD sufferers. In this review, we consider the current status of TRD from four perspectives: the challenge of developing an appropriate regulatory framework for novel rapidly acting antidepressants; the efficacy of non-pharmacological somatic therapies; the development of an animal model of TRD and its use to understand the neural basis of antidepressant non-response; and the potential for rapid antidepressant action from targets (such as 5-HT receptors) beyond the glutamate receptor. LINKED ARTICLES: This article is part of a themed issue on New discoveries and perspectives in mental and pain disorders. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v179.17/issuetoc.

Citing Articles

Residual Fatigue in Unipolar and Bipolar Depression: A Systematic Review.

Pastuszak M, Cubala W, Jakuszkowiak-Wojten K, Kwasny A, Swieczkowski D, Galuszko-Wegielnik M Neuropsychopharmacol Rep. 2025; 45(1):e12519.

PMID: 39783764 PMC: 11713126. DOI: 10.1002/npr2.12519.


(-)-Syringaresinol Exerts an Antidepressant-like Activity in Mice by Noncompetitive Inhibition of the Serotonin Transporter.

Wu Y, Cai J, Liu H, Li C, Tang Q, Zhang Y Pharmaceuticals (Basel). 2025; 17(12.

PMID: 39770479 PMC: 11678425. DOI: 10.3390/ph17121637.


Bifidobacteria with indole-3-lactic acid-producing capacity exhibit psychobiotic potential via reducing neuroinflammation.

Qian X, Li Q, Zhu H, Chen Y, Lin G, Zhang H Cell Rep Med. 2024; 5(11):101798.

PMID: 39471819 PMC: 11604549. DOI: 10.1016/j.xcrm.2024.101798.


Sleep alterations in treatment-resistant depression patients undergoing ketamine treatment.

Kwasny A, Cubala W, Wlodarczyk A, Pastuszak K Pharmacol Rep. 2024; 76(6):1325-1332.

PMID: 39207673 PMC: 11582297. DOI: 10.1007/s43440-024-00641-1.


The Search for Consistency in Residual Symptoms in Major Depressive Disorder: A Narrative Review.

Pastuszak M, Cubala W, Kwasny A, Mechlinska A J Pers Med. 2024; 14(8).

PMID: 39202019 PMC: 11355381. DOI: 10.3390/jpm14080828.